Wize Pharma, Inc. (62) | Uncategorized (12)
Recent Contracts
-
At The Market Offering Agreement between Mawson Infrastructure Group Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on May 27, 2022)
-
Description of Securities
(Filed With SEC on March 21, 2022)
-
Resignation letter of Or Eisenberg
(Filed With SEC on August 20, 2021)
-
Amendment to Convertible Loans Agreements dated November 29, 2019
(Filed With SEC on July 27, 2021)
-
Warrants issued to W Capital Advisors Pty Limited
(Filed With SEC on June 9, 2021)
-
Description of Securities
(Filed With SEC on March 1, 2021)
-
Deed of Amendment, dated January 18, 2021, of the Bid Implementation Agreement between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020
(Filed With SEC on January 19, 2021)
-
Form of Contingent Value Rights Agreement
(Filed With SEC on January 19, 2021)
-
Bid Implementation Agreement, between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020
(Filed With SEC on January 5, 2021)
-
Form of Contingent Value Rights Agreement
(Filed With SEC on January 5, 2021)
-
Description of Securities
(Filed With SEC on March 30, 2020)
-
Chairman Agreement between the Company and Mark Sieczkarek dated as of April 23, 2019
(Filed With SEC on April 29, 2019)
